The presence of IL-4 enhances tumor metastasis and the highly metastatic variant of B16 melanoma (B16F10) induces a distinct CD4 T cell subset capable of strong IL-4 production compared with T cells induced by the low metastatic variant (B16F1). Here, CD4 is linked to melanoma.